Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Christopher Rentsch and Frank Hester.
Christopher Rentsch
Connection Strength
1.101
Frank Hester
  1. Hydroxychloroquine treatment does not reduce COVID-19 mortality; underdosing to the wrong patients? - Authors' reply. Lancet Rheumatol. 2021 Mar; 3(3):e172-e173.
    View in: PubMed
    Score: 0.232
  2. Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality: a population-based cohort study in patients with rheumatoid arthritis or systemic lupus erythematosus using the OpenSAFELY platform. Lancet Rheumatol. 2021 Jan; 3(1):e19-e27.
    View in: PubMed
    Score: 0.228
  3. Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records in situ using OpenSAFELY. Br J Gen Pract. 2021 11; 71(712):e806-e814.
    View in: PubMed
    Score: 0.061
  4. Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform. BMJ. 2021 07 14; 374:n1592.
    View in: PubMed
    Score: 0.060
  5. Factors associated with deaths due to COVID-19 versus other causes: population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform. Lancet Reg Health Eur. 2021 Jul; 6:100109.
    View in: PubMed
    Score: 0.059
  6. Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform. Lancet. 2021 05 08; 397(10286):1711-1724.
    View in: PubMed
    Score: 0.059
  7. Identifying Care Home Residents in Electronic Health Records - An OpenSAFELY Short Data Report. Wellcome Open Res. 2021; 6:90.
    View in: PubMed
    Score: 0.059
  8. Association between living with children and outcomes from covid-19: OpenSAFELY cohort study of 12 million adults in England. BMJ. 2021 03 18; 372:n628.
    View in: PubMed
    Score: 0.058
  9. Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February. Euro Surveill. 2021 03; 26(11).
    View in: PubMed
    Score: 0.058
  10. Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts. Ann Rheum Dis. 2021 07; 80(7):943-951.
    View in: PubMed
    Score: 0.058
  11. HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform. Lancet HIV. 2021 01; 8(1):e24-e32.
    View in: PubMed
    Score: 0.057
  12. Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform. Lancet Respir Med. 2020 11; 8(11):1106-1120.
    View in: PubMed
    Score: 0.057
  13. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020 08; 584(7821):430-436.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.